Literature DB >> 21979047

Complement factor H binds malondialdehyde epitopes and protects from oxidative stress.

David Weismann1, Karsten Hartvigsen, Nadine Lauer, Keiryn L Bennett, Hendrik P N Scholl, Peter Charbel Issa, Marisol Cano, Hubert Brandstätter, Sotirios Tsimikas, Christine Skerka, Giulio Superti-Furga, James T Handa, Peter F Zipfel, Joseph L Witztum, Christoph J Binder.   

Abstract

Oxidative stress and enhanced lipid peroxidation are linked to many chronic inflammatory diseases, including age-related macular degeneration (AMD). AMD is the leading cause of blindness in Western societies, but its aetiology remains largely unknown. Malondialdehyde (MDA) is a common lipid peroxidation product that accumulates in many pathophysiological processes, including AMD. Here we identify complement factor H (CFH) as a major MDA-binding protein that can block both the uptake of MDA-modified proteins by macrophages and MDA-induced proinflammatory effects in vivo in mice. The CFH polymorphism H402, which is strongly associated with AMD, markedly reduces the ability of CFH to bind MDA, indicating a causal link to disease aetiology. Our findings provide important mechanistic insights into innate immune responses to oxidative stress, which may be exploited in the prevention of and therapy for AMD and other chronic inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979047      PMCID: PMC4826616          DOI: 10.1038/nature10449

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  42 in total

Review 1.  Age-related macular degeneration.

Authors:  Rama D Jager; William F Mieler; Joan W Miller
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

Review 2.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

3.  Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells.

Authors:  F Takizawa; S Tsuji; S Nagasawa
Journal:  FEBS Lett       Date:  1996-11-18       Impact factor: 4.124

4.  A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.

Authors:  Anne E Hughes; Nick Orr; Hossein Esfandiary; Martha Diaz-Torres; Timothy Goodship; Usha Chakravarthy
Journal:  Nat Genet       Date:  2006-09-24       Impact factor: 38.330

5.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

6.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

7.  Proinflammatory effects of advanced lipoxidation end products in monocytes.

Authors:  Narkunarajaa Shanmugam; James L Figarola; Yan Li; Piotr M Swiderski; Samual Rahbar; Rama Natarajan
Journal:  Diabetes       Date:  2007-11-14       Impact factor: 9.461

8.  C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack.

Authors:  Leendert A Trouw; Anders A Bengtsson; Kyra A Gelderman; Björn Dahlbäck; Gunnar Sturfelt; Anna M Blom
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

9.  Induction of angiogenic cytokine expression in cultured RPE by ingestion of oxidized photoreceptor outer segments.

Authors:  Gareth T Higgins; Jiang Huai Wang; Peter Dockery; Philip E Cleary; H Paul Redmond
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-04       Impact factor: 4.799

10.  His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form.

Authors:  Simon J Clark; Victoria A Higman; Barbara Mulloy; Stephen J Perkins; Susan M Lea; Robert B Sim; Anthony J Day
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

View more
  223 in total

1.  Association between age-related decline of kidney function and plasma malondialdehyde.

Authors:  Guolin Li; Yaqin Chen; Hui Hu; Li Liu; Xiaofei Hu; Jun Wang; Wang Shi; Dazhong Yin
Journal:  Rejuvenation Res       Date:  2012-04-24       Impact factor: 4.663

Review 2.  Complement dysregulation in AMD: RPE-Bruch's membrane-choroid.

Authors:  Janet R Sparrow; Keiko Ueda; Jilin Zhou
Journal:  Mol Aspects Med       Date:  2012-04-05

Review 3.  How does the macula protect itself from oxidative stress?

Authors:  James T Handa
Journal:  Mol Aspects Med       Date:  2012-04-05

4.  Molecular medicine: Defence against oxidative damage.

Authors:  Fernando Cruz-Guilloty; Victor L Perez
Journal:  Nature       Date:  2011-10-05       Impact factor: 49.962

Review 5.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

6.  High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.

Authors:  Una L Kelly; Daniel Grigsby; Martha A Cady; Michael Landowski; Nikolai P Skiba; Jian Liu; Alan T Remaley; Mikael Klingeborn; Catherine Bowes Rickman
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

Review 7.  Nrf2 signaling is impaired in the aging RPE given an oxidative insult.

Authors:  Mira M Sachdeva; Marisol Cano; James T Handa
Journal:  Exp Eye Res       Date:  2013-11-08       Impact factor: 3.467

8.  Oxidative stress induces mitochondrial dysfunction and a protective unfolded protein response in RPE cells.

Authors:  Marisol Cano; Lei Wang; Jun Wan; Bradley P Barnett; Katayoon Ebrahimi; Jiang Qian; James T Handa
Journal:  Free Radic Biol Med       Date:  2014-01-14       Impact factor: 7.376

Review 9.  Next-generation therapeutic solutions for age-related macular degeneration.

Authors:  Khrishen Cunnusamy; Rafael Ufret-Vincenty; Shusheng Wang
Journal:  Pharm Pat Anal       Date:  2012-05

10.  Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on complement factor H haplotype.

Authors:  Roxana A Radu; Jane Hu; Zhichun Jiang; Dean Bok
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.